The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Structural Basis for the Function of Clostridium difficile Toxin B
Abstract
Toxin B is a member of the family of large clostridial cytotoxins which are of great medical importance. Its catalytic fragment was crystallized in the presence of UDP-glucose and Mn2+. The structure was determined at 2.2 A resolution, showing that toxin B belongs to the glycosyltransferase type A family. However, toxin B contains as many as 309 residues in addition to the common chainfold, which most likely contribute to the target specificity. A superposition with other glycosyltransferases shows the expected positions of the acceptor oxygen atom during glucosyl transfer and indicates further that the reaction proceeds probably along a single-displacement pathway. The C1'' donor carbon atom position is defined by the bound UDP and glucose. It assigns the surface area of toxin B that forms the interface to the target protein during the modifying reaction. A docking attempt brought the known acceptor atom, Thr37 O(gamma1) of the switch I region of the RhoA:GDP target structure, near the expected position. The relative orientation of the two proteins was consistent with both being attached to a membrane. Sequence comparisons between toxin B variants revealed that the highest exchange rate occurs around the active center at the putative docking interface, presumably due to a continuous hit-and-evasion struggle between Clostridia and their eukaryotic hosts.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In this new structure, the GalNAc moiety is placed in the active site in a conformation, which is different from the canonical tucked under conformation previously observed in other UDP-sugar-GT complex structures (7, 12, 15–18, 20–24).”
From Novel UDP-GalNAc Derivative Structures Provide Insight into the Donor Specificity of Human Blood Group Glycosyltransferase (2015) · cites this paper as [22]
Citations
Cites
Protein Structure Comparison by Alignment of Distance Matrices
Holm, L., & Sander, C. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1489 · Cited by 3,984
Research works printed but not linked: 45
- Kelly, 1998, Clostridium difficile infection, Annu. Rev. Med., 49, 375, 10.1146/annurev.med.49.1.375 · DOI · Paper page
- Kyne, 2002, Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile, Clin. Infect. Dis., 34, 346, 10.1086/338260 · DOI · Paper page
- Stoddart, 2002, Clostridium difficile, Curr. Opin. Infect. Dis., 15, 513, 10.1097/00001432-200210000-00010 · DOI
- Busch, 2000, Microbial toxins and the glycosylation of Rho family GTPases, Curr. Opin. Struct. Biol., 10, 528, 10.1016/S0959-440X(00)00126-3 · DOI
- Just, 1995, Glucosylation of Rho proteins by Clostridium difficile toxin B, Nature, 375, 500, 10.1038/375500a0 · DOI · Paper page
- Just, 2004, Large clostridial cytotoxins, Rev. Physiol. Biochem. Pharmacol., 152, 23, 10.1007/s10254-004-0033-5 · DOI · Paper page
- Etienne-Manneville, 2002, Rho GTPases in cell biology, Nature, 420, 629, 10.1038/nature01148 · DOI · Paper page
- Popoff, 1996, Ras, Rap, and Rac small GTP-binding proteins are targets for Clostridium sordellii lethal toxin glucosylation, J. Biol. Chem., 271, 10217, 10.1074/jbc.271.17.10217 · DOI · Paper page
- Just, 1996, Inactivation of Ras by Clostridium sordellii lethal toxin-catalyzed glucosylation, J. Biol. Chem., 271, 10149, 10.1074/jbc.271.17.10149 · DOI · Paper page
- Ciesla, 1998, Clostridium difficile toxins A and B are cation-dependent UDP-glucose hydrolases with differing catalytic activities, J. Biol. Chem., 273, 16021, 10.1074/jbc.273.26.16021 · DOI
- Rupnik, 2005, Characterization of the cleavage site and function of resulting cleavage fragments after limited proteolysis of Clostridium difficile toxin B (TcdB) by host cells, Microbiology, 151, 199, 10.1099/mic.0.27474-0 · DOI
- Hofmann, 1997, Localization of the glucosyltransferase activity of Clostridium difficile toxin B to the N-terminal part of the holotoxin, J. Biol. Chem., 272, 11074, 10.1074/jbc.272.17.11074 · DOI · Paper page
- Ünligil, 2000, Glycosyltransferase structure and mechanism, Curr. Opin. Struct. Biol., 10, 510, 10.1016/S0959-440X(00)00124-X · DOI · Paper page
- Gibbons, 2002, Crystal structure of the autocatalytic initiator of glycogen biosynthesis, glycogenin, J. Mol. Biol., 319, 463, 10.1016/S0022-2836(02)00305-4 · DOI
- Persson, 2001, Crystal structure of the retaining galactosyltransferase LgtC from Neisseria meningitides in complex with donor and acceptor sugar analogs, Nature Struct. Biol., 8, 166, 10.1038/84168 · DOI
- Gastinel, 2001, Bovine α-1,3-galactosyltransferase catalytic domain structure and its relationship with ABO histo-blood group and glycosphingolipid glycosyltransferases, EMBO J., 20, 638, 10.1093/emboj/20.4.638 · DOI · Paper page
- Ünligil, 2000, X-ray crystal structure of rabbit N-acetylglucosaminyltransferase I: catalytic mechanism and a new protein superfamily, EMBO J., 19, 5269, 10.1093/emboj/19.20.5269 · DOI · Paper page
- Qasba, 2005, Substrate-induced conformational changes in glycosyltransferases, Trends Biochem. Sci., 30, 53, 10.1016/j.tibs.2004.11.005 · DOI · Paper page
- Tvaroska, 2004, Molecular modeling insights into the catalytic mechanism of the retaining galactosyltransferase LgtC, Carbohydr. Res., 339, 1007, 10.1016/j.carres.2003.11.014 · DOI
- Vetter, 2000, Structural consequences of mono-glucosylation of Ha-Ras by Clostridium sordellii lethal toxin, J. Mol. Biol., 301, 1091, 10.1006/jmbi.2000.4045 · DOI
- Lairson, 2004, Intermediate trapping on a mutant retaining α-galactosyltransferase identifies an unexpected aspartate residue, J. Biol. Chem., 279, 28339, 10.1074/jbc.M400451200 · DOI
- Boix, 2002, Structural basis of ordered binding of donor and acceptor substrates to the retaining glycosyltransferase, α-1,3-galactosyltransferase, J. Biol. Chem., 277, 28310, 10.1074/jbc.M202631200 · DOI · Paper page
- Pedersen, 2003, Crystal structure of an α-1,4-N-acetylhexosaminyltransferase (EXTL2), a member of the exostosin gene family involved in heparin sulfate biosynthesis, J. Biol. Chem., 278, 14420, 10.1074/jbc.M210532200 · DOI
- Negishi, 2003, Glucosaminylglycan biosynthesis: what we can learn form the X-ray crystal structures of glycosyltransferases GlcAT1 and EXTL2, Biochem. Biophys. Res. Commun., 303, 393, 10.1016/S0006-291X(03)00356-5 · DOI · Paper page
- Ihara, 1998, Crystal structure of human RhoA in a dominantly active form complexed with a GTP analogue, J. Biol. Chem., 273, 9656, 10.1074/jbc.273.16.9656 · DOI · Paper page
- Genth, 1999, Monoglucosylation of RhoA at threonine 37 blocks cytosol-membrane cycling, J. Biol. Chem., 274, 29050, 10.1074/jbc.274.41.29050 · DOI
- Hoffman, 2000, Structure of the Rho family GTP-binding protein Cdc42 in complex with the multifunctional regulator RhoGDI, Cell, 100, 345, 10.1016/S0092-8674(00)80670-4 · DOI · Paper page
- Shimizu, 2000, An open conformation of switch I revealed by the crystal structure of a Mg2+-free form of RhoA complexed with GDP. Implications for the GDP/GTP exchange mechanism, J. Biol. Chem., 275, 18311, 10.1074/jbc.M910274199 · DOI
- Mesmin, 2004, A phosphatidylserine-binding site in the cytosolic fragment of Clostridium sordellii lethal toxin facilitates glucosylation of membrane-bound Rac and is required for cytotoxicity, J. Biol. Chem., 279, 49876, 10.1074/jbc.M406903200 · doi:10.1074/jbc.m406903200
- Solski, 2002, RhoA biological activity is dependent on prenylation but independent of specific isoprenoid modification, Cell Growth Differ., 13, 363
- Hofmann, 1998, Chimeric clostridial cytotoxins: identification of the N-terminal region involved in protein substrate recognition, Infect. Immun., 66, 1076, 10.1128/IAI.66.3.1076-1081.1998 · DOI
- Kabsch, 1993, Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants, J. Appl. Crystallog., 26, 795, 10.1107/S0021889893005588 · DOI · Paper page
- Schneider, 2002, Substructure solution with SHELXD, Acta Crystallog. sect. D, 58, 1772, 10.1107/S0907444902011678 · DOI · Paper page
- De la Fortelle, 1997, Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods, Methods Enzymol., 276, 472, 10.1016/S0076-6879(97)76073-7 · DOI · Paper page
- 1994, The CCP4 suite: programs for protein crystallography, Acta Crystallog. sect. D, 50, 760, 10.1107/S0907444994003112 · DOI · Paper page
- Terwilliger, 2000, Maximum likelihood density modification, Acta Crystallog. sect. D, 56, 965, 10.1107/S0907444900005072 · DOI · Paper page
- Perrakis, 1999, Automated protein model building combined with iterative structure refinement, Nature Struct. Biol., 6, 458, 10.1038/8263 · DOI
- Brünger, 1998, Crystallography & NMR system: a new software suite for macromolecular structure determination, Acta Crystallog. sect. D, 54, 905, 10.1107/S0907444998003254 · DOI · Paper page
- Jones, 1991, Improved methods for building protein models in electron density maps and the location of errors in these models, Acta Crystallog. sect. A, 47, 110, 10.1107/S0108767390010224 · DOI · Paper page
- McRee, 1999, XtalView/Xfit—a versatile program for manipulating atomic coordinates and electron density, J. Struct. Biol., 125, 156, 10.1006/jsbi.1999.4094 · DOI · Paper page
- Schüttelkopf, 2004, PRODRG: a tool for high-throughput crystallography of protein–ligand complexes, Acta Crystallog. sect. D, 60, 1355, 10.1107/S0907444904011679 · DOI · Paper page
- Fenn, 2003, POVScript+: a program for model and data visualization using persistence of vision ray-tracing, J. Appl. Crystallog., 36, 944, 10.1107/S0021889803006721 · DOI · Paper page
- Morgenstern, 2004, DIALIGN: multiple DNA and protein sequence alignment at BiBiServ, Nucl. Acids Res., 32, W33, 10.1093/nar/gkh373 · DOI · Paper page
- Gabb, 1997, Modelling protein docking using shape complementarity, electrostatics and biochemical information, J. Mol. Biol., 272, 106, 10.1006/jmbi.1997.1203 · DOI · Paper page
- Moont, 1999, Use of pair potentials across protein interfaces in screening predicted docked complexes, Proteins: Struct. Funct. Genet., 35, 364, 10.1002/(SICI)1097-0134(19990515)35:3<364::AID-PROT11>3.0.CO;2-4 · DOI · Paper page
Cited by
Glycosyltransferases: Structures, Functions, and Mechanisms
Lairson, L. L., Henrissat, B., Davies, G. J., & Withers, S. G. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.061005.092322 · Cited by 2,079
Emergence of Clostridium difficile-associated disease in North America and Europe
Kuijper, E. J., Coignard, B., & Tüll, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01580.x · Cited by 855
Zhang, D., de Souza, R. F., Anantharaman, V., Iyer, L. M., & Aravind, L. (2012) · Biology Direct · doi:10.1186/1745-6150-7-18 · Cited by 515
The role of toxins in Clostridium difficile infection
Chandrasekaran, R., & Lacy, D. B. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux048 · Cited by 353
Recent structural insights into the expanding world of carbohydrate-active enzymes
Davies, G. J., Gloster, T. M., & Henrissat, B. (2005) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2005.10.008 · Cited by 314
Clostridium difficile Toxin Biology
Aktories, K., Schwan, C., & Jank, T. (2017) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090816-093458 · Cited by 297
Self-citationStructure and mode of action of clostridial glucosylating toxins: the ABCD model
Jank, T., & Aktories, K. (2008) · Trends in Microbiology · doi:10.1016/j.tim.2008.01.011 · Cited by 279
Self-citationAnantharaman, V., Makarova, K. S., Burroughs, A. M., Koonin, E. V., & Aravind, L. (2013) · Biology Direct · doi:10.1186/1745-6150-8-15 · Cited by 262
Ng, J., Hirota, S. A., Gross, O., Li, Y., Ulke–Lemee, A., Potentier, M. S., Schenck, L. P., Vilaysane, A., Seamone, M. E., Feng, H., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.005 · Cited by 258
Popoff, M. R. (2018) · Toxicon · doi:10.1016/j.toxicon.2017.11.003 · Cited by 23
Wagner, G. K., Pesnot, T., Palcic, M. M., & Jørgensen, R. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.681262 · Cited by 12
Metadata
- Authors
- Reinert, D. J., Jank, T., Aktories, K., & Schulz, G. E.
- Venue
- Journal of Molecular Biology
- Publisher
- Elsevier BV
- Published
- 2005-09
- Volume
- 351
- Issue
- 5
- Pages
- 973-981
- ISSN
- 0022-2836
- Cited by
- 132
- References
- 1
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.